These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15614553)

  • 1. Modelling human granulopoiesis under poly-chemotherapy with G-CSF support.
    Scholz M; Engel C; Loeffler M
    J Math Biol; 2005 Apr; 50(4):397-439. PubMed ID: 15614553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.
    Scholz M; Schirm S; Wetzler M; Engel C; Loeffler M
    Theor Biol Med Model; 2012 Jul; 9():32. PubMed ID: 22846180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment.
    Schirm S; Engel C; Loeffler M; Scholz M
    Theor Biol Med Model; 2014 May; 11():24. PubMed ID: 24886056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-based design of chemotherapeutic regimens that account for heterogeneity in leucopoenia.
    Scholz M; Engel C; Loeffler M;
    Br J Haematol; 2006 Mar; 132(6):723-35. PubMed ID: 16487172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation.
    Østby I; Rusten LS; Kvalheim G; Grøttum P
    J Math Biol; 2003 Aug; 47(2):101-36. PubMed ID: 12883857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling chemotherapy effects on granulopoiesis.
    Schirm S; Engel C; Loeffler M; Scholz M
    BMC Syst Biol; 2014 Dec; 8():138. PubMed ID: 25539928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapy.
    Engel C; Scholz M; Loeffler M
    Blood; 2004 Oct; 104(8):2323-31. PubMed ID: 15226178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human haematopoiesis in steady state and following intense perturbations.
    Shochat E; Stemmer SM; Segel L
    Bull Math Biol; 2002 Sep; 64(5):861-86. PubMed ID: 12391860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
    Lemoli RM; Rosti G; Visani G; Gherlinzoni F; Miggiano MC; Fortuna A; Zinzani P; Tura S
    J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
    Ballestrero A; Ferrando F; Garuti A; Basta P; Gonella R; Stura P; Mela GS; Sessarego M; Gobbi M; Patrone F
    J Clin Oncol; 1999 Apr; 17(4):1296. PubMed ID: 10561192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of G-CSF and IL-6 in the granulopoiesis-stimulating activity of murine blood serum induced by perorally administered ultrafiltered pig leukocyte extract, IMUNOR.
    Vacek A; Hofer M; Holá J; Weiterová L; Streitová D; Svoboda J
    Int Immunopharmacol; 2007 May; 7(5):656-61. PubMed ID: 17386413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
    Bernstein SH; Fay JP; Christiansen NP; Pinero L; Shah D; Stephan M; Herzig GP
    Clin Cancer Res; 1997 Sep; 3(9):1519-26. PubMed ID: 9815838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis.
    Schmitz S; Franke H; Brusis J; Wichmann HE
    Exp Hematol; 1993 Jun; 21(6):755-60. PubMed ID: 7684699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of granulocyte colony-stimulating factor on hematopoietic injury induced by anticancer drugs in mice.
    Mizushima Y; Morikage T; Kuwahara T; Yano S
    J Biol Response Mod; 1990 Dec; 9(6):576-83. PubMed ID: 1705961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
    van Os R; Robinson S; Sheridan T; Mauch PM
    Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
    Elias AD; Ayash L; Tepler I; Wheeler C; Schwartz G; Mazanet R; Schnipper L; Frei E; Antman K
    J Hematother; 1993; 2(3):377-82. PubMed ID: 7522891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.
    Sugawara Y; Fisher SJ; Zasadny KR; Kison PV; Baker LH; Wahl RL
    J Clin Oncol; 1998 Jan; 16(1):173-80. PubMed ID: 9440740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.